MDMarisol Devesa

Marisol Devesa

*This is an algorithmically generated author record based on publicly available information.

Marisol Devesa has a total of 5 co-authors. Here are the top co-authors by number of shared publications:

  • Flor Helene Pujol

    Laboratorio de Virologia Molecular, Centro de Microbiología y Biología Celular (CMBC), Instituto Venezolano de Investigaciones Científicas (IVIC), Caracas 1020, Venezuela

    2 shared publications
  • Carmen Luisa Loureiro

    Laboratorio de Virología Molecular, Centro de Microbiología y Biología Celular, Instituto Venezolano de Investigaciones Científicas, Caracas, Miranda, Venezuela

    1 shared publication
  • Cristina Gutiérrez

    Laboratorio de Virología Molecular, CMBC, IVIC, Caracas, Venezuela

    1 shared publication
  • Ferdinando Liprandi

    Laboratorio de Biología de Virus, CMBC, IVIC, Caracas, Venezuela

    1 shared publication
  • Graciela León

    Banco Municipal de Sangre, Caracas, Venezuela

    1 shared publication

Latest Publications

  • Hepatitis B virus genetic diversity in Latin America

    by Marisol Devesa, Flor H. Pujol


  • Molecular and serological evaluation of surface antigen negative hepatitis B virus infection in blood donors from Venezuela

    by Cristina Gutiérrez, Marisol Devesa, Carmen Luisa Loureiro, Graciela León, Ferdinando Liprandi, Flor Helene Pujol

    Surface antigen negative hepatitis B virus (HBV) infection was evaluated in Venezuela, by molecular characterization of blood samples positive for antibodies to core antigen (anti‐HBc) and negative for surface antigen (HBsAg) in blood donors (residual infections). HBV DNA was found in 11/258 samples (4.3%), and was significantly associated with high levels of anti‐HBc antibodies (>25 UI/ml, P < 0.05), while no correlation was found between the presence of HBV DNA and the levels of anti‐HBs. Synonymous and non‐synonymous mutations were found in the HBV surface region (but not vaccine escape mutants) and in the precore/core region (precore mutants in 2/7 samples and 33–45 bp deletions near the N‐terminal core region in 4/19 samples). While HBV genotype F prevails among HBsAg positive samples from blood donors in Venezuela, residual infection isolates were mainly genotypes A and D. Phylogenetic analysis of viral surface and core region revealed discrepancies in genotype designation in 6/9 samples, suggesting the presence of mixed infection or recombination. In conclusion, HBV residual infection in Venezuela does not seem to be frequently observed in HBV genotype F. This type of infection is frequently associated with variants exhibiting mutations in the surface gene that might be affecting the correct recognition by commercial tests, with precore mutants and with core internal deletions. These variants do not seem to cause severe liver disease, and on the contrary, were found circulating at low viremia. J. Med. Virol. 73:200–207, 2004.